The state of California currently has 61 active clinical trials seeking participants for Alzheimer's Disease research studies. These trials are conducted in various cities, including Los Angeles, San Francisco, San Diego and Sacramento.
Sequential Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of TB006 in Healthy Subjects
NCT04920786
Recruiting
This is a single dose, dose-escalation study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of TB006, a monoclonal antibody that will be studied as a disease modifying treatment for Alzheimer's disease.
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
06/03/2021
Locations: Collaborative Neuroscience Research, LLC (CNS), Long Beach, California
Conditions: Alzheimer Disease
Register for Updates